Rational Investing

	Total Market Capitalization of All Firms	709052 mm
	Average Market Capitalization	32230 mm
	Average Market to Model Ratio Weighted by Log of Market Cap	0.94
	Standard Deviation of MM Ratio	0.02
	Average Beta	1.11
	Average EV To Revenue	5.98
	Average Price To Free Cash Flow	141.52

Ticker	Company Name	Market To Model	Market Cap ($ mm)	EV to Revenue	Price To FCF	% Growth	Beta	As Of
QGEN	Qiagen Nv	2.0	7,873	6.1	67.9	11	1.01	Sep 18
CBM	Cambrex Corp.	1.7	1,364	2.5	64.6	5	2.25	Sep 18
GEN.CO	Genmab A/S	1.6	12,536	4.1	43.2	31	1.24	Jun 18
INCY	Incyte Corp.	1.5	13,628	7.0	76.0	26	0.96	Sep 18
ILMN	Illumina Inc.	1.3	47,660	14.6	65.3	22	1.05	Sep 18
CSL.AX	CSL Ltd.	1.2	58,605	6.8	84.9	17	0.98	Jun 18
ICLR	Icon Plc	1.2	7,218	3.9	22.0	9	0.66	Sep 18
QIA.DE	Qiagen NV	1.1	8,961	6.9	42.4	10	1.05	Sep 18
BTG.L	Btg Plc	1.0	4,022	6.2	1916.8	5	0.32	Mar 18
VRTX	Vertex Pharmaceuticals Inc.	1.0	43,064	14.1	54.7	24	1.57	Sep 18
ERF.PA	Eurofins Scientific SE	0.9	6,362	2.4	-91.9	21	0.88	Jun 18
REGN	Regeneron Pharmaceuticals Inc	0.9	40,412	6.2	18.5	13	1.32	Sep 18
ALKS	Alkermes, Inc.	0.8	4,786	4.8	-102.1	17	1.51	Sep 18
AMGN	Amgen Inc	0.8	140,152	7.4	14.9	4	1.35	Sep 18
CRL	Charles River Laboratories Hol	0.7	5,948	3.2	-12.3	21	0.80	Sep 18
BIIB	Biogen Idec	0.6	66,512	5.3	12.8	12	0.98	Sep 18
JAZZ	Jazz Pharmaceuticals plc	0.6	8,443	5.5	10.6	13	0.96	Sep 18
UCB.BR	UCB SA	0.6	15,990	3.7	14.6	9	0.83	Jun 18
SHPG	Shire Plc	0.5	52,105	4.2	9.5	12	1.21	Sep 18
ALXN	Alexion Pharmaceuticals Inc	0.4	24,427	6.8	17.1	14	1.04	Sep 18
CELG	Celgene Corp	0.4	53,354	4.6	-12.4	16	1.40	Sep 18
GILD	Gilead Sciences Inc	0.4	85,630	5.2	11.5	-12	1.03	Sep 18